Literature DB >> 9495735

Behavioral modification for institutionalized individuals with urinary incontinence.

P D O'Donnell1.   

Abstract

OBJECTIVES: To review the evaluation of urinary incontinence (UI) in institutionalized individuals and to discuss the use of behavioral modification in this population.
METHODS: The functional characteristics and patterns of incontinence typical of the institutionalized population are described to explain the rationale for the use of behavioral therapies.
RESULTS: Both mental and physical status must be evaluated when considering behavioral therapies for UI in institutionalized patients. Institutionalized individuals often have significant functional impairment that prevents the use of behavioral therapies requiring extensive patient participation. Assessments of bladder function and the severity of UI are also important when planning therapy. In appropriate candidates, a prompted voiding program can be expected to reduce the severity of incontinence and improve the quality of life, even though normal bladder control is rarely achieved. Standardized protocols for the implementation of a prompted voiding program have been developed.
CONCLUSIONS: Few treatment options for UI are feasible for use in institutionalized individuals. However, prompted voiding can reduce the severity of UI in most of these patients and will thereby improve the quality of life.

Entities:  

Mesh:

Year:  1998        PMID: 9495735     DOI: 10.1016/s0090-4295(98)90008-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  2 in total

1.  Study protocol: ICONS: identifying continence options after stroke: a randomised trial.

Authors:  Lois H Thomas; Caroline L Watkins; Beverley French; Christopher Sutton; Denise Forshaw; Francine Cheater; Brenda Roe; Michael J Leathley; Christopher Burton; Elaine McColl; Jo Booth
Journal:  Trials       Date:  2011-05-20       Impact factor: 2.279

2.  Identifying continence options after stroke (ICONS): a cluster randomised controlled feasibility trial.

Authors:  Lois H Thomas; Caroline L Watkins; Christopher J Sutton; Denise Forshaw; Michael J Leathley; Beverley French; Christopher R Burton; Francine Cheater; Brenda Roe; David Britt; Joanne Booth; Elaine McColl
Journal:  Trials       Date:  2014-12-23       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.